Smylie MG - Search Results

1

A phase II, open label, monotherapy study of liposomal doxorubicin in patients with metastatic malignant melanoma.

Smylie MG, Wong R, Mihalcioiu C, Lee C, Pouliot JF. Smylie MG, et al. Invest New Drugs. 2007 Apr;25(2):155-9. doi: 10.1007/s10637-006-9002-y. Epub 2006 Sep 7. Invest New Drugs. 2007. PMID: 16957835 Clinical Trial.

2

Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancer.

Nabholtz JM, Smylie M, Mackey J, Paterson A, Noel D, al-Tweigeri, Janowska A, Delorme F, Riva A. Nabholtz JM, et al. Oncology (Williston Park). 1997 Jun;11(6 Suppl 6):25-7. Oncology (Williston Park). 1997. PMID: 9213324 Clinical Trial.

3

Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancer.

Nabholtz JM, Smylie M, Mackey JR, Noel D, Paterson AH, al-Tweigeri T, Au D, Sansregret E, Delorme F, Riva A. Nabholtz JM, et al. Oncology (Williston Park). 1997 Aug;11(8 Suppl 8):37-41. Oncology (Williston Park). 1997. PMID: 9364541 Clinical Trial.

4

Taxane-based three-drug combination in metastatic and adjuvant treatment of breast cancer.

Nabholtz JM, Mackey J, Smylie M, Tonkin K. Nabholtz JM, et al. Semin Oncol. 1998 Oct;25(5 Suppl 12):27-31. Semin Oncol. 1998. PMID: 9865709 Clinical Trial.

5

Review of docetaxel and doxorubicin-based combinations in the management of breast cancer: from metastatic to adjuvant setting.

Nabholtz JM, Tonkin K, Smylie M, Mackey J, Janowska-Wieczorek A. Nabholtz JM, et al. Semin Oncol. 1999 Feb;26(1 Suppl 3):10-6. Semin Oncol. 1999. PMID: 10203265 Review.

6

Phase II study of docetaxel, doxorubicin, and cyclophosphamide as first-line chemotherapy for metastatic breast cancer.

Nabholtz JM, Mackey JR, Smylie M, Paterson A, Noël DR, Al-Tweigeri T, Tonkin K, North S, Azli N, Riva A. Nabholtz JM, et al. J Clin Oncol. 2001 Jan 15;19(2):314-21. doi: 10.1200/JCO.2001.19.2.314. J Clin Oncol. 2001. PMID: 11208821 Clinical Trial.

7

Final results of a phase II clinical trial of weekly docetaxel in combination with capecitabine in anthracycline-pretreated metastatic breast cancer.

Mackey JR, Tonkin KS, Koski SL, Scarfe AG, Smylie MG, Joy AA, Au HJ, Bodnar DM, Soulieres D, Smith SW. Mackey JR, et al. Among authors: smylie mg. Clin Breast Cancer. 2004 Oct;5(4):287-92. doi: 10.3816/cbc.2004.n.032. Clin Breast Cancer. 2004. PMID: 15507175 Clinical Trial.

8

Phase II study of perifosine in previously untreated patients with metastatic melanoma.

Ernst DS, Eisenhauer E, Wainman N, Davis M, Lohmann R, Baetz T, Belanger K, Smylie M. Ernst DS, et al. Invest New Drugs. 2005 Dec;23(6):569-75. doi: 10.1007/s10637-005-1157-4. Invest New Drugs. 2005. PMID: 16034524 Clinical Trial.

9

Management of malignant melanoma: best practices.

Smylie M, Claveau J, Alanen K, Taillefer R, George R, Wong R, Mason WP; Canadian Expert Panel on Malignant Melanoma. Smylie M, et al. J Cutan Med Surg. 2009 Mar-Apr;13(2):55-73. doi: 10.2310/7750.2008.08029. J Cutan Med Surg. 2009. PMID: 19459245 Review.

10

Improved survival with vemurafenib in melanoma with BRAF V600E mutation.

Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, Hogg D, Lorigan P, Lebbe C, Jouary T, Schadendorf D, Ribas A, O'Day SJ, Sosman JA, Kirkwood JM, Eggermont AM, Dreno B, Nolop K, Li J, Nelson B, Hou J, Lee RJ, Flaherty KT, McArthur GA; BRIM-3 Study Group. Chapman PB, et al. N Engl J Med. 2011 Jun 30;364(26):2507-16. doi: 10.1056/NEJMoa1103782. Epub 2011 Jun 5. N Engl J Med. 2011. PMID: 21639808 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

79 results

Search Page